Bruce Ovbiagele1, Jeffrey L Saver. 1. Stroke Center and Department of Neurology, University of California at Los Angeles Medical Center, Los Angeles, CA 90095, USA. Ovibes@mednet.ucla.edu
Abstract
BACKGROUND: White matter hyperintensities (WMH) are commonly observed MRI abnormalities in the elderly, which generally reflect covert vascular brain injury. WMH cumulatively produce substantial neurologic, psychiatric, and medical morbidity. This review provides an overview of current knowledge on vascular WMH, and describes some pharmacological agents that may have a role in mitigating this condition. SUMMARY OF REVIEW: This review has two main focus areas. The first is a discussion of currently available knowledge regarding the public health burden, pathogenesis, and various risk factors associated with the presence of vascular white matter lesions noted on brain MRI. The second section of the article details the mechanistic and clinical basis for promising pharmacological treatment modalities that could potentially prevent progression of ischemic cerebral white matter brain injury. Many of these therapies are already of proven efficacy in preventing recurrent stroke. CONCLUSIONS: Individuals with vascular white matter lesions on MRI may represent a potential target population likely to benefit from secondary stroke prevention therapies. Copyright 2006 S. Karger AG, Basel.
BACKGROUND: White matter hyperintensities (WMH) are commonly observed MRI abnormalities in the elderly, which generally reflect covert vascular brain injury. WMH cumulatively produce substantial neurologic, psychiatric, and medical morbidity. This review provides an overview of current knowledge on vascular WMH, and describes some pharmacological agents that may have a role in mitigating this condition. SUMMARY OF REVIEW: This review has two main focus areas. The first is a discussion of currently available knowledge regarding the public health burden, pathogenesis, and various risk factors associated with the presence of vascular white matter lesions noted on brain MRI. The second section of the article details the mechanistic and clinical basis for promising pharmacological treatment modalities that could potentially prevent progression of ischemic cerebral white matter brain injury. Many of these therapies are already of proven efficacy in preventing recurrent stroke. CONCLUSIONS: Individuals with vascular white matter lesions on MRI may represent a potential target population likely to benefit from secondary stroke prevention therapies. Copyright 2006 S. Karger AG, Basel.
Authors: Christa Watson; Edgar Busovaca; Jessica M Foley; I Elaine Allen; Christopher G Schwarz; Neda Jahanshad; Talia M Nir; Pardis Esmaeili-Firidouni; Benedetta Milanini; Howard Rosen; Owen T Carmichael; Paul M Thompson; Victor G Valcour Journal: J Neurovirol Date: 2017-01-18 Impact factor: 2.643
Authors: Virawudh Soontornniyomkij; Anya Umlauf; Sandra A Chung; Megan L Cochran; Benchawanna Soontornniyomkij; Ben Gouaux; Will Toperoff; David J Moore; Eliezer Masliah; Ronald J Ellis; Igor Grant; Cristian L Achim Journal: AIDS Date: 2014-06-01 Impact factor: 4.177
Authors: Zachary A Corbin; Natalia S Rost; Svetlana Lorenzano; Walter N Kernan; Michael K Parides; Jeffrey B Blumberg; Paul E Milbury; Ken Arai; Sophia N Hartdegen; Eng H Lo; Steven K Feske; Karen L Furie Journal: J Stroke Cerebrovasc Dis Date: 2014-01-16 Impact factor: 2.136
Authors: Christopher M Holland; Eric E Smith; Istvan Csapo; Mahmut Edip Gurol; Douglas A Brylka; Ronald J Killiany; Deborah Blacker; Marilyn S Albert; Charles R G Guttmann; Steven M Greenberg Journal: Stroke Date: 2008-02-21 Impact factor: 7.914
Authors: Saskia G C van Elderen; A Brandts; J J M Westenberg; J van der Grond; J T Tamsma; M A van Buchem; J A Romijn; L J M Kroft; J W A Smit; A de Roos Journal: Eur Radiol Date: 2009-11-14 Impact factor: 5.315